UNIGE document Scientific Article
previous document  unige:45947  next document
add to browser collection
Title

Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.
Authors
Diamantopoulos, Alex
Finckh, Axel
Huizinga, T
Sungher, D K
Sawyer, L
Neto, David
Dejonckheere, F
Published in PharmacoEconomics. 2014, vol. 32, no. 8, p. 775-87
Abstract Since receiving a positive recommendation in England, Wales and Scotland, tocilizumab (TCZ) is one of the options available to clinicians for the treatment of rheumatoid arthritis (RA) patients in the UK.
Identifiers
PMID: 24854959
Full text
Article (Published version) (881 Kb) - public document Free access
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine interne des spécialités
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format) 		DIAMANTOPOULOS, Alex et al. Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK. In: PharmacoEconomics, 2014, vol. 32, n° 8, p. 775-87. https://archive-ouverte.unige.ch/unige:45947

208 hits

285 downloads

Contact an author

Update request

Update

Deposited on : 2015-01-28

Export document
Format :
Citation style :